Selected research
Industry Research
Non-Clinical CRO Services Industry Research Report 2026
Market perspective
The global Non-Clinical CRO Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Non-Clinical CRO Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Non-Clinical CRO Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Non-Clinical CRO Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Non-Clinical CRO Services include CMIC Group, Shanghai Innostar Biotech, ApconiX, Charles River Laboratories, ERBC Group, STILLMEADOW and ICON, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Non-Clinical CRO Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Non-Clinical CRO Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Non-Clinical CRO Services Market by Company
CMIC Group
Shanghai Innostar Biotech
ApconiX
Charles River Laboratories
ERBC Group
STILLMEADOW
ICON
Non-Clinical CRO Services Segment by Type
Safety Pharmacology Testing
Administration Toxicity Test
Reproductive Toxicity Test
Genotoxicity Test
Immunogenicity Studies
Carcinogenicity Test
Other
Non-Clinical CRO Services Segment by Application
Pharmaceutical Center
Institute
Hospital
Non-Clinical CRO Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Clinical CRO Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-Clinical CRO Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Clinical CRO Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Non-Clinical CRO Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Safety Pharmacology Testing
- Administration Toxicity Test
- Reproductive Toxicity Test
- Genotoxicity Test
- Immunogenicity Studies
- Carcinogenicity Test
- Other
Applications
- Pharmaceutical Center
- Institute
- Hospital
Companies covered
- CMIC Group
- Shanghai Innostar Biotech
- ApconiX
- Charles River Laboratories
- ERBC Group
- STILLMEADOW
- ICON
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Non-Clinical CRO Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Safety Pharmacology Testing
- 2.2.3 Administration Toxicity Test
- 2.2.4 Reproductive Toxicity Test
- 2.2.5 Genotoxicity Test
- 2.2.6 Immunogenicity Studies
- 2.2.7 Carcinogenicity Test
- 2.2.8 Other
- 2.3 Non-Clinical CRO Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Center
- 2.3.3 Institute
- 2.3.4 Hospital
- 2.4 Assumptions and Limitations
3 Non-Clinical CRO Services Breakdown Data by Type
- 3.1 Global Non-Clinical CRO Services Historic Market Size by Type (2021-2026)
- 3.2 Global Non-Clinical CRO Services Forecasted Market Size by Type (2027-2032)
4 Non-Clinical CRO Services Breakdown Data by Application
- 4.1 Global Non-Clinical CRO Services Historic Market Size by Application (2021-2026)
- 4.2 Global Non-Clinical CRO Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Non-Clinical CRO Services Market Perspective (2021-2032)
- 5.2 Global Non-Clinical CRO Services Growth Trends by Region
- 5.2.1 Global Non-Clinical CRO Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Non-Clinical CRO Services Historic Market Size by Region (2021-2026)
- 5.2.3 Non-Clinical CRO Services Forecasted Market Size by Region (2027-2032)
- 5.3 Non-Clinical CRO Services Market Dynamics
- 5.3.1 Non-Clinical CRO Services Industry Trends
- 5.3.2 Non-Clinical CRO Services Market Drivers
- 5.3.3 Non-Clinical CRO Services Market Challenges
- 5.3.4 Non-Clinical CRO Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Non-Clinical CRO Services Players by Revenue
- 6.1.1 Global Top Non-Clinical CRO Services Players by Revenue (2021-2026)
- 6.1.2 Global Non-Clinical CRO Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Non-Clinical CRO Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Non-Clinical CRO Services Head Office and Area Served
- 6.4 Global Non-Clinical CRO Services Players, Product Type & Application
- 6.5 Global Non-Clinical CRO Services Manufacturers Established Date
- 6.6 Global Non-Clinical CRO Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Non-Clinical CRO Services Market Size (2021-2032)
- 7.2 North America Non-Clinical CRO Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Non-Clinical CRO Services Market Size by Country (2021-2026)
- 7.4 North America Non-Clinical CRO Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Non-Clinical CRO Services Market Size (2021-2032)
- 8.2 Europe Non-Clinical CRO Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Non-Clinical CRO Services Market Size by Country (2021-2026)
- 8.4 Europe Non-Clinical CRO Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Non-Clinical CRO Services Market Size (2021-2032)
- 9.2 Asia-Pacific Non-Clinical CRO Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Non-Clinical CRO Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Non-Clinical CRO Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Non-Clinical CRO Services Market Size (2021-2032)
- 10.2 South America Non-Clinical CRO Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Non-Clinical CRO Services Market Size by Country (2021-2026)
- 10.4 South America Non-Clinical CRO Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Non-Clinical CRO Services Market Size (2021-2032)
- 11.2 Middle East & Africa Non-Clinical CRO Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Non-Clinical CRO Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Non-Clinical CRO Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 CMIC Group
- 12.1.1 CMIC Group Company Information
- 12.1.2 CMIC Group Business Overview
- 12.1.3 CMIC Group Revenue in Non-Clinical CRO Services Business (2021-2026)
- 12.1.4 CMIC Group Non-Clinical CRO Services Product Portfolio
- 12.1.5 CMIC Group Recent Developments
- 12.2 Shanghai Innostar Biotech
- 12.2.1 Shanghai Innostar Biotech Company Information
- 12.2.2 Shanghai Innostar Biotech Business Overview
- 12.2.3 Shanghai Innostar Biotech Revenue in Non-Clinical CRO Services Business (2021-2026)
- 12.2.4 Shanghai Innostar Biotech Non-Clinical CRO Services Product Portfolio
- 12.2.5 Shanghai Innostar Biotech Recent Developments
- 12.3 ApconiX
- 12.3.1 ApconiX Company Information
- 12.3.2 ApconiX Business Overview
- 12.3.3 ApconiX Revenue in Non-Clinical CRO Services Business (2021-2026)
- 12.3.4 ApconiX Non-Clinical CRO Services Product Portfolio
- 12.3.5 ApconiX Recent Developments
- 12.4 Charles River Laboratories
- 12.4.1 Charles River Laboratories Company Information
- 12.4.2 Charles River Laboratories Business Overview
- 12.4.3 Charles River Laboratories Revenue in Non-Clinical CRO Services Business (2021-2026)
- 12.4.4 Charles River Laboratories Non-Clinical CRO Services Product Portfolio
- 12.4.5 Charles River Laboratories Recent Developments
- 12.5 ERBC Group
- 12.5.1 ERBC Group Company Information
- 12.5.2 ERBC Group Business Overview
- 12.5.3 ERBC Group Revenue in Non-Clinical CRO Services Business (2021-2026)
- 12.5.4 ERBC Group Non-Clinical CRO Services Product Portfolio
- 12.5.5 ERBC Group Recent Developments
- 12.6 STILLMEADOW
- 12.6.1 STILLMEADOW Company Information
- 12.6.2 STILLMEADOW Business Overview
- 12.6.3 STILLMEADOW Revenue in Non-Clinical CRO Services Business (2021-2026)
- 12.6.4 STILLMEADOW Non-Clinical CRO Services Product Portfolio
- 12.6.5 STILLMEADOW Recent Developments
- 12.7 ICON
- 12.7.1 ICON Company Information
- 12.7.2 ICON Business Overview
- 12.7.3 ICON Revenue in Non-Clinical CRO Services Business (2021-2026)
- 12.7.4 ICON Non-Clinical CRO Services Product Portfolio
- 12.7.5 ICON Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst